Politicians have urged authorities in Europe to allow physicians to prescribe regulatory-approved cannabis-based medicines, saying regulation could translate into additional revenue for public authorities and ensure quality and accurate labelling.
Last week (February 13), members of the European Parliament adopted a resolution calling on the European Commission and national authorities to draw a clear distinction between medical cannabis and other uses of cannabis.
They urged Member States to allow doctors to "use their professional judgement" in prescribing cannabis-based medicines saying "the regulation of cannabis-based medicines would translate into additional revenue for public authorities, would limit the black market and ensure quality and accurate labelling. It would also limit minors’ access to this substance".
The MEPs said that when effective, these medicines should be covered by health insurance schemes in the same way as other types of medicine.
They also called on Member States to provide medical professionals with proper medical training in this area and to encourage increased knowledge on medical cannabis based on independent and wide-ranging research.
MEPs have also urged the Commission and Member States to address regulatory, financial and cultural barriers which burden scientific research and called for properly fund research in the area.